{"nctId":"NCT01924065","briefTitle":"Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation","startDateStruct":{"date":"2013-08"},"conditions":["Atrial Fibrillation","Cardioversion","Cerebrovascular Stroke"],"count":112,"armGroups":[{"label":"Transesophageal Echocardiography group","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Cardioversion"]},{"label":"Oral anticoagulant Group","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Cardioversion","Drug: Oral Anticoagulant"]}],"interventions":[{"name":"Cardioversion","otherNames":[]},{"name":"Oral Anticoagulant","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients with the age of more than 18 years who are planned to undergo electrical or medical cardioversion\n\nExclusion Criteria:\n\n* Urgent cardioversion\n* Patients who have implanted pace-makers or other metal devices\n* Claustrophobia\n* Hematological disorders disabling patients to receive anticoagulant agents\n* Atrial fibrillation secondary to temporary causes.\n* Serious rheumatic heart valve disease\n* Hyperthyroidism\n* History of malignancy\n* Left atrium diameter \\> 55 mm\n* Ejection fraction \\< 0.25","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Combined Clinical Thromboembolic or Hemorrhagic Event, Death or Silent Cerebral Thromboemboli","description":"Clinical events during 2 years follow-up or silent cerebral thromboemboli detected by diffusion magnetic resonance imaging at 1 week post-cardioversion","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"PRIMARY","title":"Efficacy Clinical End-point","description":"Any Clinical Thromboembolic Event, Death or Silent Cerebral Thromboemboli","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]},{"type":"PRIMARY","title":"Ischemic Stroke/Transient Ischemic Attack","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"PRIMARY","title":"Acute Ischemia in MRI","description":"Development of acute silent cerebral ischemia detected by MRI","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"PRIMARY","title":"Mortality","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Hemorrhagic Stroke","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]},{"type":"PRIMARY","title":"Gastrointestinal Bleeding","description":null,"paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":9,"n":56},"commonTop":[]}}}